BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37088561)

  • 1. Serum level of apoptosis inhibitor of macrophage in dogs with histiocytic sarcoma and its association with the disease.
    Uchida M; Matsumiya Y; Tsuboi M; Uchida K; Nakagawa T; Fujii W; Kobayashi T; Tsujimoto H; Ohmi A; Tomiyasu H; Motegi T; Maeda S; Momoi Y; Yonezawa T
    Vet Comp Oncol; 2023 Sep; 21(3):391-400. PubMed ID: 37088561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptosis inhibitor of macrophage (AIM) reduces cell number in canine histiocytic sarcoma cell lines.
    Uchida M; Saeki K; Maeda S; Tamahara S; Yonezawa T; Matsuki N
    J Vet Med Sci; 2016 Oct; 78(9):1515-1520. PubMed ID: 27246397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variations in Histiocytic Differentiation of Cell Lines From Canine Cerebral and Articular Histiocytic Sarcomas.
    Thongtharb A; Uchida K; Chambers JK; Nakayama H
    Vet Pathol; 2017 May; 54(3):395-404. PubMed ID: 28178429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA in situ hybridisation as a molecular diagnostic technique targeting IBA-1 and CD204 in canine histiocytic sarcoma.
    Engelien JL; Lejeune AT; Dark MJ; Milner RJ; Shiomitsu K
    Vet Med Sci; 2022 Jul; 8(4):1400-1408. PubMed ID: 35339118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of a survivin suppressor YM155 on the chemoresistance of canine histiocytic sarcoma cells.
    Yamazaki H; Takagi S; Hosoya K; Okumura M
    Vet J; 2015 Sep; 205(3):375-80. PubMed ID: 26048444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the drug sensitivity and expression of 16 drug resistance-related genes in canine histiocytic sarcoma cell lines.
    Asada H; Tomiyasu H; Goto-Koshino Y; Fujino Y; Ohno K; Tsujimoto H
    J Vet Med Sci; 2015 Jun; 77(6):677-84. PubMed ID: 25715778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Matrix metalloproteinases expression in spontaneous canine histiocytic sarcomas and its xenograft model.
    Fayyad A; Lapp S; Risha E; Pfankuche VM; Rohn K; Barthel Y; Schaudien D; Baumgärtner W; Puff C
    Vet Immunol Immunopathol; 2018 Apr; 198():54-64. PubMed ID: 29571518
    [TBL] [Abstract][Full Text] [Related]  

  • 8. mRNA sequencing analysis and growth inhibitory effects of palbociclib on cell lines from canine histiocytic proliferative disorders.
    Hirabayashi M; Chambers JK; Tani A; Tomiyasu H; Motegi T; Rimpo K; Nakayama H; Uchida K
    Vet Comp Oncol; 2022 Sep; 20(3):587-601. PubMed ID: 35278028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Passage-dependent morphological and phenotypical changes of a canine histiocytic sarcoma cell line (DH82 cells).
    Heinrich F; Contioso VB; Stein VM; Carlson R; Tipold A; Ulrich R; Puff C; Baumgärtner W; Spitzbarth I
    Vet Immunol Immunopathol; 2015 Jan; 163(1-2):86-92. PubMed ID: 25534080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced angiogenic gene expression in morbillivirus-triggered oncolysis in a translational model for histiocytic sarcoma.
    Pfankuche VM; Spitzbarth I; Lapp S; Ulrich R; Deschl U; Kalkuhl A; Baumgärtner W; Puff C
    J Cell Mol Med; 2017 Apr; 21(4):816-830. PubMed ID: 27860224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of dasatinib in a xenograft mouse model of canine histiocytic sarcoma and in vitro expression status of its potential target EPHA2.
    Ito K; Miyamoto R; Tani H; Kurita S; Kobayashi M; Tamura K; Bonkobara M
    J Vet Pharmacol Ther; 2018 Feb; 41(1):e45-e48. PubMed ID: 28833247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 2-base insertion in exon 5 is a common mutation of the TP53 gene in dogs with histiocytic sarcoma.
    Asada H; Tsuboi M; Chambers JK; Uchida K; Tomiyasu H; Goto-Koshino Y; Ohno K; Tsujimoto H
    J Vet Med Sci; 2017 Oct; 79(10):1721-1726. PubMed ID: 28867679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTPN11 mutations in canine and human disseminated histiocytic sarcoma.
    Hédan B; Rault M; Abadie J; Ulvé R; Botherel N; Devauchelle P; Copie-Bergman C; Cadieu E; Parrens M; Alten J; Zalcman EL; Cario G; Damaj G; Mokhtari K; Le Loarer F; Coulomb-Lhermine A; Derrien T; Hitte C; Bachelot L; Breen M; Gilot D; Blay JY; Donadieu J; André C
    Int J Cancer; 2020 Sep; 147(6):1657-1665. PubMed ID: 32212266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment and characterisation of cell lines and xenograft mouse models of canine systemic histiocytosis and disseminated histiocytic sarcoma.
    Hirabayashi M; Chambers JK; Kishimoto TE; Nguyen SV; Ishikawa Y; Rimpo K; Nakayama H; Uchida K
    Vet Comp Oncol; 2022 Jun; 20(2):465-475. PubMed ID: 34907644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of expression and prognostic implications of transforming growth factor beta, programmed death-ligand 1, and T regulatory cells in canine histiocytic sarcoma.
    Murphy JD; Shiomitsu K; Milner RJ; Lejeune A; Ossiboff RJ; Gell JC; Axiak-Bechtel S
    Vet Immunol Immunopathol; 2023 Mar; 257():110560. PubMed ID: 36804838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of the two-base insertion mutation in the TP53 gene in canine histiocytic sarcoma.
    Asada H; Tomiyasu H; Okada K; Chambers JK; Goto-Koshino Y; Uchida K; Kagawa Y; Ohno K; Tsujimoto H
    Res Vet Sci; 2019 Jun; 124():57-60. PubMed ID: 30852355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gain-of-function mutation in PTPN11 in histiocytic sarcomas of Bernese Mountain Dogs.
    Thaiwong T; Sirivisoot S; Takada M; Yuzbasiyan-Gurkan V; Kiupel M
    Vet Comp Oncol; 2018 Jun; 16(2):220-228. PubMed ID: 28929581
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel canine histiocytic sarcoma cell line: initial characterization and utilization for drug screening studies.
    Takada M; Parys M; Gregory-Bryson E; Vilar Saavedra P; Kiupel M; Yuzbasiyan-Gurkan V
    BMC Cancer; 2018 Mar; 18(1):237. PubMed ID: 29490634
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A review of histiocytic diseases of dogs and cats.
    Moore PF
    Vet Pathol; 2014 Jan; 51(1):167-84. PubMed ID: 24395976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistent Infection of a Canine Histiocytic Sarcoma Cell Line with Attenuated Canine Distemper Virus Expressing Vasostatin or Granulocyte-Macrophage Colony-Stimulating Factor.
    Marek K; Armando F; Nippold VM; Rohn K; Plattet P; Brogden G; Gerold G; Baumgärtner W; Puff C
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.